Results overview: Found 59 records in 0.02 seconds.
Articles, 32 records found
Research literature, 27 records found
Articles 32 records found  1 - 10nextend  jump to record:
1.
50 p, 829.6 KB ¿Por qué las mujeres con cáncer de mama deben estar guapas y los hombres con cáncer de próstata pueden ir sin afeitar? : Oncología, disidencia y cultura hegemónica / Sumalla, Enric-Claudi (Institut Català d'Oncologia) ; Castejón Itey, Vanessa (Institut Català d'Oncologia) ; Ochoa, Cristian (Institut Català d'Oncologia) ; Blanco Guillermo, Ignacio (Institut Català d'Oncologia)
El universo oncológico, aparentemente, constituye un ámbito de profundos consensos; aliviar el sufrimiento de pacientes y familias, la búsqueda de una cura efectiva o erradicar el estigma asociado al diagnóstico son objetivos que generan un amplio acuerdo social. [...]
The oncology universe apparently is an area of deep consensus; alleviate the suffering of patients and families, the search for an effective cure or eradicate the stigma associated with the diagnosis are objectives that generate broad societal agreement. [...]

2013 - 10.5209/rev_PSIC.2013.v10.41946
Psicooncología, Vol. 10 Núm. 1 (2013) , p. 7-56  
2.
22 p, 18.3 MB Estado emocional en mujeres con cáncer de mama : variación experimentada después de una sesión psico-oncológica basada en el counselling y la psicología positiva / Vila Sánchez, Lídia (Universitat Autònoma de Barcelona. Facultat de Psicologia) ; Font Guiteras, Antoni (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ; Caba Vela, Lydia (Hospital Comarcal Sant Jaume de Calella (Catalunya))
Objetivo: La mayoría de estudios sobre los beneficios de la intervención psicológica en pacientes de cáncer de mama se han centrado en los efectos acumulados después de varias sesiones terapéuticas. [...]
Objective: Most studies on psychological intervention benefits have focused on the effects after several therapeutic sessions. The objective of this research was to describe the patients' emotional state, and establish the possible immediate emotional effects of an individual psycho-oncological session. [...]

2016 - 10.5209/PSIC.54433
Psicooncología, Vol. 13 Núm. 2-3 (2016) , p. 205-225  
3.
9 p, 652.1 KB ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas / Castellana, Bàrbara (Institut d'Investigació Biomèdica Sant Pau) ; Escuin, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Peiró, Gloria (Hospital General Universitario de Alicante) ; Garcia Valdecasas, Bárbara (Universitat Autònoma de Barcelona) ; Vázquez, Tania (Institut d'Investigació Biomèdica Sant Pau) ; Pons, Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Pérez Olabarria, Maitane (Institut d'Investigació Biomèdica Sant Pau) ; Barnadas i Molins, Agustí (Universitat Autònoma de Barcelona. Departament de Medicina) ; Lerma Puertas, Enrique (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques)
The mechanism of progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) remains largely unknown. We compared gene expression in tumors with simultaneous DCIS and IDC to decipher how diverse proteins participate in the local invasive process. [...]
2012 - 10.7150/jca.4120
Journal of Cancer, Vol. 3, Núm. 1 (2012) , p. 175-183  
4.
14 p, 4.6 MB Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases / De Mattos-Arruda, Leticia (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Ng, Charlotte K. Y. (Department of Biomedicine, University of Basel, Basel, Switzerland) ; Piscuoglio, Salvatore (Institute of Pathology, University Hospital Basel) ; Gonzalez-Cao, Maria (Hospital Universitari Quirón Dexeus) ; Lim, Raymond S. (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; De Filippo, Maria R. (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Fusco, Nicola (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Schultheis, Anne M. (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Ortiz, Carolina (Vall d'Hebron Institut d'Oncologia) ; Viteri, Santiago (Hospital Universitari Quirón Dexeus) ; Arias, Alexandra (Vall d'Hebron Institut d'Oncologia) ; Macedo, Gabriel S. (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Oliveira, Mafalda (Vall d'Hebron Institut d'Oncologia) ; Gomez, Patricia (Vall d'Hebron Institut d'Oncologia) ; Teixidó, Cristina (Hospital Universitari Quirón Dexeus) ; Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ; Peg, Vicente (Vall d'Hebron Institut de Recerca) ; Saura, Cristina (Vall d'Hebron Institut d'Oncologia) ; Ramon y Cajal, Santiago (Vall d'Hebron Institut de Recerca) ; Tresserra Casas, Francesc (Hospital Universitari Quirón Dexeus) ; Weigelt, Britta (Department of Pathology, Memorial Sloan Kettering Cancer Center) ; Cortes, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Seoane Suárez, Joan (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Reis-Filho, Jorge S. (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)
Brain metastases constitute a challenge in the management of patients with HER2-positive breast cancer treated with anti-HER2 systemic therapies. Here we sought to define the repertoire of mutations private to or enriched for in HER2-positive brain metastases. [...]
2018 - 10.18632/oncotarget.25041
Oncotarget, Vol. 9 (april 2018) , p. 20617-20630  
5.
16 p, 352.3 KB Patient-centered care in breast cancer genetic clinics / Brédart, Anne (Univesité Paris Descartes) ; Anota, Amélie (Centre Hospitalier Régional Universitaire de Besançon) ; Dick, Julia (Cancer Center Cologne) ; Kuboth, Violetta (Cancer Center Cologne) ; Lareyre, Olivier (Institut Curie) ; De Pauw, Antoine (Institut Curie) ; Cano, Alejandra (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ; Stoppa-Lyonnet, Dominique (Institut Curie) ; Schmutzler, Rita (Cancer Center Cologne) ; Dolbeault, Sylvie (Centre de Recherche en Épidémiologie et Santé des Populations (CESP)) ; Kop, Jean-Luc (Université de Lorraine)
With advances in breast cancer (BC) gene panel testing, risk counseling has become increasingly complex, potentially leading to unmet psychosocial needs. We assessed psychosocial needs and correlates in women initiating testing for high genetic BC risk in clinics in France and Germany, and compared these results with data from a literature review. [...]
2018 - 10.3390/ijerph15020319
International journal of environmental research and public health, Vol. 15 (february 2018)  
6.
23 p, 9.1 MB MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells / Sánchez-Cid, Lourdes (Instituto de Salud Carlos III. CIBER de Bioingeniería, Biomateriales y Nanomedicina) ; Pons, Mònica (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Lozano, Juan José (Instituto de Salud Carlos III. Centro de investigación biomédica en red. Enfermedades hepáticas y digestivas (CIBER-EHD)) ; Rubio, Nuria (Institut de Química avançada de Catalunya (IQAC-CSIC)) ; Guerra-Rebollo, Marta (Institut de Química avançada de Catalunya (IQAC-CSIC)) ; Soriano, Aroa (Vall d'Hebron Institut de Recerca (VHIR)) ; Paris-Coderch, Laia (Vall d'Hebron Institut de Recerca (VHIR)) ; Segura, Miquel F. (Vall d'Hebron Institut de Recerca (VHIR)) ; Fueyo, Raquel (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Arguimbau, Judit (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Zodda, Erika (Universitat de Barcelona. Departament de Bioquímica i Biologia molecular) ; Bermudo, Raquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Alonso, Immaculada (Hospital Clínic de Barcelona. Departament d'Obstetrícia i Ginecologia) ; Caparrós, Xavier (Hospital Clínic de Barcelona. Departament d'Obstetrícia i Ginecologia) ; Cascante, Marta (Universitat de Barcelona. Departament de Bioquímica i Biologia molecular) ; Rafii, Arash (Weill Cornell Medical College. Education City (Ar-Rayyan, Qatar)) ; Kang, Yibin (Princeton University. Department of Molecular Biology) ; Martínez-Balbás, Marian (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Weiss, Stephen J. (University of Michigan. Life Sciences Institute) ; Blanco, Jerónimo (Institut de Química avançada de Catalunya (IQAC-CSIC)) ; Muñoz, Montserrat (Hospital Clínic de Barcelona. Departament d'Oncologia) ; Fernández, Pedro L. (Universitat de Barcelona. Facultat de Medicina) ; Thomson, Timothy M. (Consell Superior d'Investigacions Científiques. Institut de Biologia Molecular (IBMB-CSIC)) ; Universitat Autònoma de Barcelona
MicroRNAs are critical regulators of gene networks in normal and abnormal biological processes. Focusing on invasive ductal breast cancer (IDC), we have found dysregulated expression in tumor samples of several microRNAs, including the miR-200 family, along progression from primary tumors to distant metastases, further reflected in higher blood levels of miR-200b and miR-7 in IDC patients with regional or distant metastases relative to patients with primary node-negative tumors. [...]
2017 - 10.18632/oncotarget.20698
Oncotarget, Vol. 8, Num. 48 (October 2017) , p. 83384-83406  
7.
12 p, 675.8 KB Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer : Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG / Hadji, Peyman (Krankenhaus Nordwest) ; Aapro, Matti S. (Genolier Cancer Center, Switzerland) ; Body, Jean-Jacques (CHU Brugmann, Université Libre de Bruxelles, Belgium) ; Gnant, Michael (Medical University of Vienna, Austria) ; Brandi, Maria Luisa (University of Florence, Italy) ; Reginster, Jean Yves (University of Liège, Belgium) ; Zillikens, M. Carola (Erasmus MC, Rotterdam, Netherlands) ; Glüer, Claus-C. (Univeristy of Kiel, Germany) ; de Villiers, Tobie (University of Stellenbosch, Cape Town, South Africa) ; Baber, Rod (University of Sydney, Australia) ; Roodman, G. David (Indiana University School of Medicine, USA) ; Cooper, Cyrus (University of Southampton, UK) ; Langdahl, Bente (Aarhus University, Denmark) ; Palacios, Santiago (Instituto Palacios Madrid, Spain) ; Kanis, John (Catholic University of Australia, Melbourne, Australia and University of Sheffield, UK) ; Al-Daghri, Nasser (University of Riyadh, Saudi Arabia) ; Nogués Solán, Xavier (Universitat Autònoma de Barcelona) ; Eriksen, Erik Fink (University of Oslo, Norway) ; Kurth, Andreas (Klinikum Birkenwerder, Germany) ; Rizzoli, Rene (Geneva University, Switzerland) ; Coleman, Robert E. (University of Sheffield, UK)
Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor (AI) therapy. Recently, a number of studies on additional fracture related risk factors, new treatment options as well as real world studies demonstrating a much higher fracture rate than suggested by randomized clinical controlled trials (RCTs). [...]
2017 - 10.1016/j.jbo.2017.03.001
Journal of Bone Oncology, Vol. 7 (June 2017) , p. 1-12  
8.
13 p, 2.7 MB Breast primary epithelial cells that escape p16-dependent stasis enter a telomere-driven crisis state / Feijoo, Purificación (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Terradas Ill, Mariona (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Soler, David (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Domínguez, Daniel (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Tusell Padrós, Laura (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Genescà, A. (Anna) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Breast cancer is the most common malignant disease in women, but some basic questions remain in breast cancer biology. To answer these, several cell models were developed. Recently, the use of improved cell-culture conditions has enabled the development of a new primary cell model with certain luminal characteristics. [...]
2016 - 10.1186/s13058-015-0667-z
Breast cancer research, Vol. 18 (January 2016) , art. 7  
9.
14 p, 6.7 MB Differential expression of neurogenes among breast cancer subtypes identifies high risk patients / Fernández-Nogueira, Patricia (Department of Medicine, University of Barcelona) ; Bragado, Paloma (Department of Medical Oncology, Hospital Clínic) ; Almendro, Vanessa (Division of Medical Oncology, Department of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Brigham and Women's Hospital) ; Ametller, Elisabet (Institut d'Investigacions Biomediques August Pi i Sunyer Barcelona) ; Rios, Jose (Universitat Autònoma de Barcelona. Departament de Medicina) ; Choudhury, Sibgat (Division of Medical Oncology, Department of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Brigham and Women's Hospital) ; Mancino, Mario (Institut d'Investigacions Biomediques August Pi i Sunyer Barcelona) ; Gascón, Pedro (Department of Medicine, University of Barcelona)
The nervous system is now recognized to be a relevant component of the tumor microenvironment. Receptors for neuropeptides and neurotransmitters have been identified in breast cancer. However, very little is known about the role of neurogenes in regulating breast cancer progression. [...]
2015 - 10.18632/oncotarget.6543
Oncotarget, Vol. 7 (december 2015) , p. 5313-5326  
10.
18 p, 2.6 MB Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells / Castellana, Bàrbara (Departments of Department of Obstetrics and Gynecology, Child and Family Research Institute, University of British Columbia) ; Aasen, Trond (Vall d'Hebron Institut de Recerca. Patologia molecular) ; Moreno-Bueno, Gema (Instituto de Investigaciones Biomédicas "Alberto Sols" CSIC-UAM) ; Dunn, Sandra E. (Phoenix Molecular Diagnostics Ltd., Richmond) ; Ramón y Cajal, Santiago (Vall d'Hebron Institut de Recerca (VHIR). Patologia molecular) ; Universitat Autònoma de Barcelona
Epithelial to mesenchymal transition (EMT) induces cell plasticity and promotes metastasis. The multifunctional oncoprotein Y-box binding protein-1 (YB-1) and the pleiotropic cytokine interleukin 6 (IL-6) have both been implicated in tumor cell metastasis and EMT, but via distinct pathways. [...]
2015
Oncotarget, Vol. 6 (october 2015) , p. 38239-38256  

Articles : 32 records found   1 - 10nextend  jump to record:
Research literature 27 records found  1 - 10nextend  jump to record:
1.
1 p, 1.4 MB Design and engineering of trastuzumab emtansine production plant : part III, upstream, bioreactions and fermentation of the antitumorigenic agent Ansamitocin P3 / Puig Laborda, Víctor ; Universitat Autònoma de Barcelona. Facultat de Biociències
2018
Grau en Biotecnologia [815]  
2.
1 p, 2.3 MB Design and engineering of trastuzumab emtansine production plant : part I, introduction to T-DM1 production process and upstream of monoclonal antibody trastuzumab / Salse Guiu, Laura ; Universitat Autònoma de Barcelona. Facultat de Biociències
2018
Grau en Biotecnologia [815]  
3.
29 p, 724.4 KB Correlation Between Ultrasonography and Magnetic Resonance Imaging with Pathology-Measured Tumor Size in Women with Recently Diagnosed Breast Cancer. Optimizing tumor-size estimation with imaging techniques for higher precision / Brenner Anidjar, Rony-David ; Luna Tomás, Miguel-Ángel, dir. ; Universitat Autònoma de Barcelona. Facultat de Medicina
The use of Breast-MRI in surgical planning of breast cancer is a field of controversy due to its high sensitivity but low specificity, alongside with overestimation of tumor-size. It has been proven many factors contribute to this overestimation. [...]
El uso de Resonancia Magnética Mamaria (RMM) en la planificación pre-quirúrgica del cáncer de mama es controvertido dada la alta sensibilidad y baja especificidad, junto con la sobreestimación del tamaño tumoral. [...]

2017
Grau en Medicina [1192]  
4.
1 p, 942.9 KB The role of ALDHbr BCSCs as prognostic markers and therapeutic targets in breast cancer / Grima Reyes, Manuel ; Farrés i Vicén, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2016
Grau en Bioquímica [814]  
5.
1 p, 17.8 MB Proteomics application in breast cancer / Blanco Vega, Noemí ; Bassols Teixidó, Anna Maria, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  
6.
1 p, 2.5 MB Anticancer prodrugs, the new way of using nanoparticles / Jiménez Giménez, Esther ; Farrés i Vicén, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  
7.
1 p, 5.4 MB MicroRNAs' role in epithelial-mesenchymal transition in breast cancer / Delowar Akther, Hossain ; Itarte, Emili, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  
8.
1 p, 1.0 MB Breast cancer stem cells generated through the epithelial mesenchymal transition / Ibars Sillés, Patricia ; Itarte, Emili, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  
9.
1 p, 8.1 MB Monoubiquitination linked to regulation transcriptional mechanism in breast cancer / Poch Coronel, John Jesús ; Roque Córdova, Alicia, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  
10.
1 p, 2.7 MB Role of Trastuzumab in HER2+ breast cancer : importance of combined theraphy / Ceriol García-Jáudenes, Carlos ; Jiménez Altayó, Francesc, dir. (Universitat Autònoma de Barcelona.Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Ciències Biomèdiques [832]  

Research literature : 27 records found   1 - 10nextend  jump to record:
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.